首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   22195篇
  免费   2078篇
  国内免费   58篇
耳鼻咽喉   255篇
儿科学   706篇
妇产科学   410篇
基础医学   3041篇
口腔科学   357篇
临床医学   2451篇
内科学   4451篇
皮肤病学   407篇
神经病学   1932篇
特种医学   763篇
外国民族医学   3篇
外科学   2848篇
综合类   569篇
现状与发展   30篇
一般理论   14篇
预防医学   2236篇
眼科学   739篇
药学   1606篇
中国医学   25篇
肿瘤学   1488篇
  2023年   259篇
  2022年   111篇
  2021年   334篇
  2020年   293篇
  2019年   382篇
  2018年   423篇
  2017年   327篇
  2016年   374篇
  2015年   451篇
  2014年   637篇
  2013年   873篇
  2012年   1242篇
  2011年   1328篇
  2010年   701篇
  2009年   749篇
  2008年   1110篇
  2007年   1282篇
  2006年   1188篇
  2005年   1207篇
  2004年   1166篇
  2003年   1004篇
  2002年   1005篇
  2001年   458篇
  2000年   486篇
  1999年   507篇
  1998年   334篇
  1997年   267篇
  1996年   267篇
  1995年   234篇
  1994年   201篇
  1993年   185篇
  1992年   316篇
  1991年   316篇
  1990年   305篇
  1989年   313篇
  1988年   283篇
  1987年   259篇
  1986年   279篇
  1985年   245篇
  1984年   210篇
  1983年   161篇
  1982年   164篇
  1981年   132篇
  1980年   134篇
  1979年   195篇
  1978年   148篇
  1977年   112篇
  1976年   114篇
  1974年   118篇
  1973年   133篇
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
1.
2.
3.
4.
5.

Introduction/Hypothesis

Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.

Methods

An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.

Results

A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.

Conclusions/Recommendations

Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial.  相似文献   
6.
7.
8.
To evaluate morbidity associated with surgical lengthening of the gastrocnemius, medical records were reviewed retrospectively for 126 patients (mean age, 49.7 years; range, 8-78 years) who had undergone open gastrocnemius recession. Ten patients had isolated recession; 116 had gastrocnemius recession with an additional foot or ankle procedure on the ipsilateral limb. During a mean follow-up period of 19 months (range, 6-50 months), all patients were examined for any postoperative complications associated with the recession. Complications were defined as the presence of postoperative infection, wound dehiscence, nerve problems, decreased muscle strength, scar problems, or calcaneus gait (overlengthening). Uncomplicated outcome was defined as absence of all these complications and return to regular activity, both occurring during a follow-up of at least 6 months. Postsurgical complications developed in 9 (6%) of the 126 patients: 6 (4%) had scar problems, 2 (1.33%) had wound dehiscence, 2 (1.33%) had infection, 3 (2%) had nerve problems, and 1 (0.67%) developed complex regional pain syndrome. No patient complained of either a limp or gait disturbance. Neither persistent decrease in muscle strength nor calcaneus gait was seen. These data suggest that the open gastrocnemius recession procedure has low associated morbidity.  相似文献   
9.
The authors present a case of rickets in an adolescent girl who presented to the emergency department with bone pain. Emergency department staff should be aware that rickets is not just a disease of early childhood.  相似文献   
10.
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号